POM PHARMA
GenericsPOM PHARMA is a generic drug manufacturer focused on Neurology, Infectious Disease, Ophthalmology.
POM PHARMA's Key Drugs
POM PHARMA's key approved drugs from the last 15 years (excludes generics, biosimilars and IV formulations).
POM PHARMA's Recent FDA Approvals
New NDA/BLA approvals for POM PHARMA over the last two years — novel drugs only, excluding generics and label supplements.
POM PHARMA's Therapeutic Areas
POM PHARMA's approved drugs and pipeline span 3 therapeutic areas, led by Neurology and Infectious Disease. Weighted by commercial stage — approved drugs count most, then late-stage trials.
POM PHARMA's Top Competitors
POM PHARMA's closest competitors by therapeutic-area and drug-target overlap include AbbVie, Pfizer, and Baxter. Ranked by overlap in therapeutic areas and drug targets across approved drugs and pipeline.
POM PHARMA Pipeline Snapshot
Active clinical trials for POM PHARMA across all therapeutic areas, from ClinicalTrials.gov.
Pro Intelligence Preview
Deep insights for investors and analysts
Revenue Insights
- • Top drug revenue breakdown
- • Drug-level revenue analysis
Trial Catalysts
- • Neurology pipeline focus
- • Phase 3 readout tracking
Patent Risk
- • Patent expiration timeline
- • Revenue at risk analysis
Compare Companies
- • Side-by-side pipeline analysis
- • Revenue & market share comparison
Revenue forecasts • Trial milestones • Patent risk modeling
Active (0)
Discontinued (0)
Company Info
- First Approval
- 1995-01-25
- Latest
- 2026-05-13
- Applications
- 5